Michael Graber

644 total citations
31 papers, 210 citations indexed

About

Michael Graber is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Michael Graber has authored 31 papers receiving a total of 210 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 6 papers in Surgery and 6 papers in Molecular Biology. Recurrent topics in Michael Graber's work include Tendon Structure and Treatment (5 papers), Aortic Disease and Treatment Approaches (4 papers) and Cardiac Valve Diseases and Treatments (4 papers). Michael Graber is often cited by papers focused on Tendon Structure and Treatment (5 papers), Aortic Disease and Treatment Approaches (4 papers) and Cardiac Valve Diseases and Treatments (4 papers). Michael Graber collaborates with scholars based in Austria, Germany and United Kingdom. Michael Graber's co-authors include Johannes Holfeld, Can Gollmann‐Tepeköylü, Michael Grimm, Daniela Lobenwein, Elisabeth Pechriggl, Leo Pölzl, Felix Nägele, Jakob Hirsch, Patrick Paulus and Uwe Primeßnig and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and European Heart Journal.

In The Last Decade

Michael Graber

29 papers receiving 199 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Graber Austria 8 57 45 40 32 29 31 210
Shuyuan Xiong China 9 27 0.5× 33 0.7× 13 0.3× 50 1.6× 14 0.5× 18 281
Tomohiro Saito Japan 12 148 2.6× 64 1.4× 15 0.4× 33 1.0× 42 1.4× 34 312
Marc Waase United States 13 36 0.6× 68 1.5× 152 3.8× 14 0.4× 10 0.3× 16 292
D Crolla Belgium 6 101 1.8× 84 1.9× 24 0.6× 12 0.4× 46 1.6× 15 326
Paula Gadeberg Denmark 5 32 0.6× 46 1.0× 22 0.6× 91 2.8× 99 3.4× 7 348
Mark Rogers United Kingdom 5 94 1.6× 34 0.8× 11 0.3× 28 0.9× 11 0.4× 10 244
J. Salama France 9 68 1.2× 125 2.8× 29 0.7× 10 0.3× 28 1.0× 35 306
Elliot L. Dimberg United States 11 40 0.7× 118 2.6× 46 1.1× 4 0.1× 19 0.7× 27 315
Takako Matsubara Japan 10 53 0.9× 49 1.1× 10 0.3× 10 0.3× 39 1.3× 28 283
Geysu Karlıkaya Türkiye 10 107 1.9× 20 0.4× 21 0.5× 8 0.3× 20 0.7× 24 334

Countries citing papers authored by Michael Graber

Since Specialization
Citations

This map shows the geographic impact of Michael Graber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Graber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Graber more than expected).

Fields of papers citing papers by Michael Graber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Graber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Graber. The network helps show where Michael Graber may publish in the future.

Co-authorship network of co-authors of Michael Graber

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Graber. A scholar is included among the top collaborators of Michael Graber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Graber. Michael Graber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Shuang, Yanqiang Li, Michael Graber, et al.. (2025). O-GlcNAcylation promotes angiogenic transdifferentiation to reverse vascular ischemia. Nature Cardiovascular Research. 4(7). 904–920. 1 indexed citations
2.
Angleitner, Philipp, Alexandra Kaider, Michael Graber, et al.. (2025). External validation of SYNTAX score II in a real-world cohort undergoing coronary artery bypass grafting. Journal of Cardiothoracic Surgery. 20(1). 324–324. 1 indexed citations
3.
Holfeld, Johannes, Felix Nägele, Leo Pölzl, et al.. (2024). Cardiac shockwave therapy in addition to coronary bypass surgery improves myocardial function in ischaemic heart failure: the CAST-HF trial. European Heart Journal. 45(29). 2634–2643. 5 indexed citations
4.
Pölzl, Leo, Felix Nägele, Jakob Hirsch, et al.. (2024). Complexity of coronary artery disease and the release of cardiac biomarkers after CABG. Frontiers in Cardiovascular Medicine. 11. 1345439–1345439.
5.
Graber, Michael, Felix Nägele, Jakob Hirsch, et al.. (2022). Prevention of Oxidative Damage in Spinal Cord Ischemia Upon Aortic Surgery: First‐In‐Human Results of Shock Wave Therapy Prove Safety and Feasibility. Journal of the American Heart Association. 11(20). 4 indexed citations
6.
Gollmann‐Tepeköylü, Can, Felix Nägele, Michael Graber, et al.. (2022). Different calcification patterns of tricuspid and bicuspid aortic valves and their clinical impact. Interactive Cardiovascular and Thoracic Surgery. 35(6). 4 indexed citations
7.
Graber, Michael, Adrian Scutelnic, Antonia Klein, et al.. (2022). Natural course of visual snow syndrome: a long-term follow-up study. Brain Communications. 4(5). fcac230–fcac230. 15 indexed citations
8.
Nägele, Felix, Michael Graber, Jakob Hirsch, et al.. (2022). Lockdown surgery: the impact of coronavirus disease 2019 measures on cardiac cases. Interactive Cardiovascular and Thoracic Surgery. 35(1). 1 indexed citations
9.
Nägele, Felix, Michael Graber, Jakob Hirsch, et al.. (2022). Correlation between structural heart disease and cardiac SARS-CoV-2 manifestations. SHILAP Revista de lepidopterología. 2(1). 142–142. 4 indexed citations
10.
Holfeld, Johannes, Felix Nägele, Michael Graber, et al.. (2022). Different Calcification Patterns of Tricuspid and Bicuspid Aortic Valves and Their Clinical Impact. The Thoracic and Cardiovascular Surgeon. 70(S 01). S1–S61. 1 indexed citations
12.
Graber, Michael, Felix Nägele, Jakob Hirsch, et al.. (2022). Cardiac Shockwave Therapy – A Novel Therapy for Ischemic Cardiomyopathy?. Frontiers in Cardiovascular Medicine. 9. 875965–875965. 5 indexed citations
13.
Pölzl, Leo, Felix Nägele, Jakob Hirsch, et al.. (2021). Defining a therapeutic range for regeneration of ischemic myocardium via shock waves. Scientific Reports. 11(1). 409–409. 4 indexed citations
14.
Pölzl, Leo, Felix Nägele, Jakob Hirsch, et al.. (2020). Exosome Isolation after in vitro Shock Wave Therapy. Journal of Visualized Experiments. 2 indexed citations
15.
Ghadge, Santhosh Kumar, et al.. (2020). ZMPSTE24 Is Associated with Elevated Inflammation and Progerin mRNA. Cells. 9(9). 1981–1981. 5 indexed citations
17.
Holfeld, Johannes, Michael Graber, Jakob Hirsch, et al.. (2018). P532Mechanical preconditioning causes microvesicle release and induces angiogenesis via thrombospondin 1. Cardiovascular Research. 114(suppl_1). S130–S130. 1 indexed citations
18.
Holfeld, Johannes, Leo Pölzl, Michael Graber, et al.. (2018). miR-19a-3p Containing Exosomes Improve Cardiac Function in Ischemic Myocardium. The Thoracic and Cardiovascular Surgeon. 66(S 01). S1–S110. 1 indexed citations
19.
Gollmann‐Tepeköylü, Can, Uwe Primeßnig, Leo Pölzl, et al.. (2016). Shockwaves prevent from heart failure after acute myocardial ischaemia via RNA/protein complexes. Journal of Cellular and Molecular Medicine. 21(4). 791–801. 19 indexed citations
20.
Boucaud, Catherine, Yves Bouffard, Jérôme Dumortier, et al.. (2008). Transoesophageal echo-Doppler vs. thermodilution cardiac output measurement during hepatic vascular exclusion in liver transplantation. European Journal of Anaesthesiology. 25(6). 485–489. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026